Systemic effect comparisons of six inhaled corticosteroid preparations (Q43997159)

28 November 2017

Systemic effect comparisons of six inhaled corticosteroid preparations (English)

1 reference

28 November 2017

9

Jeffrey M Drazen

0 references

Stanley J Szefler

2

object named as

Stanley J Szefler

1 reference

28 November 2017

17

Robert F Lemanske

1 reference

28 November 2017

11

John V Fahy

1 reference

28 November 2017

19

Christine A Sorkness

1 reference

28 November 2017

6

Homer A Boushey

1 reference

28 November 2017

3

Vernon M Chinchilli

1 reference

28 November 2017

4

Monica Kraft

1 reference

28 November 2017

15

Susan J Kunselman

1 reference

28 November 2017

5

Myrna Dolovich

1 reference

28 November 2017

10

Joanne K Fagan

1 reference

28 November 2017

Richard J Martin

1

1 reference

28 November 2017

Reuben M Cherniack

7

1 reference

28 November 2017

Timothy J Craig

8

1 reference

28 November 2017

James E Fish

12

1 reference

28 November 2017

Jean G Ford

13

1 reference

28 November 2017

Elliott Israel

14

1 reference

28 November 2017

Stephen C Lazarus

16

1 reference

28 November 2017

Stephen P Peters

18

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

1 reference

28 November 2017

165

1 reference

28 November 2017

1377-1383

1 reference

28 November 2017

10

1 reference

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

28 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

The use of low doses of ACTH in the investigation of adrenal function in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

A bioassay for topical and systemic effect of three inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2105013

21 January 2018

Identifiers

DOI

10.1164/RCCM.2105013

1 reference

28 November 2017

1 reference